Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease

Abstract

The effects of clinical grade crude preparations of human chorionic gonadotropin (hCG) on Kaposi's sarcoma, HIV, SIV and hematopoiesis were examined in vitro and in vivo. In contrast to previous studies, we report that the antiviral activity of hCG associated factors is not due to the native hCC heterodimer, including its purified subunits or its major degradation product, the β-core. Using gel permeation chromatography of the clinical grade hCC and urine concentrates from pregnant women, we demonstrate that an as yet unidentified hCG associated factor (HAF) with anti-HIV, anti-SIV, anti-KS and pro-hematopoietic activities elutes as two peaks corresponding to 15–30 kDa and 2–4 kDa.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lunardi-Iskandar, Y. et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375, 64–68 (1995).

    Article  CAS  Google Scholar 

  2. Lunardi-Iskandar, Y. et al. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J. Natl. Cancer Inst. 87, 974–981 (1995).

    Article  CAS  Google Scholar 

  3. Hermans, P. & Clumeck, N. Kaposi's sarcoma in patients infected with human immunodeficiency virus (HIV): an overview. Cell. Mol. Biol. 3, 357–364 (1995).

    Google Scholar 

  4. Gill, P.S. et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N. Engl. J. Med. 335, 1261–1269 (1996).

    Article  CAS  Google Scholar 

  5. Harris, P.J. Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin. The Lancet 346, 118–119 (1995).

    Article  CAS  Google Scholar 

  6. Gill, P. et al. Phase I study of a preparation of human chorionic gonadotropin given subcutaneously to patients with AIDS-related Kaposi's sarcoma. J. Natl. Cancer Inst. 89, 1797–1802 (1997).

    Article  CAS  Google Scholar 

  7. Hermans, P. et al. AIDS related Kaposi's sarcoma patients with visceral manifestations: response to human chorionic gonadotropin preparations. J. Human Virol. 1, 82–89 (1998).

    CAS  Google Scholar 

  8. Letvin, N.L. & King, N.W. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquir. Immune Defic. Syndr. 3, 1023–1040 (1990).

    CAS  PubMed  Google Scholar 

  9. Kestler, H. et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248, 1109–1112 (1990).

    Article  CAS  Google Scholar 

  10. Dickie, P. et al. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185, 109–119 (1991).

    Article  CAS  Google Scholar 

  11. Franks, R.R. et al. Maternal-fetal interactions affect growth of human immunodeficiency virus type 1 transgenic mice. Pediatr. Res. 37, 56–63 (1995).

    Article  CAS  Google Scholar 

  12. Kopp, J.B. et al. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. AIDS Res. Hum. Retroviruses 9, 267–275 (1993).

    Article  CAS  Google Scholar 

  13. Morse, J.H., Lustbader, J.W., Harrington, J.W. & Canfield, R.C. Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by Western blotting. Am. J. Reprod. Immunol. Microbiol. 17, 134–140 (1988).

    Article  CAS  Google Scholar 

  14. Birken, S. et al. Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. Endocrinology 123, 572–583 (1988).

    Article  CAS  Google Scholar 

  15. Morse, J.H., Stearns, G., Arden, J., Agosto, G.M. & Canfield, R.E. The effects of crude and purified human gonadotrpin on in vitro stimulated human lymphocyte cultures. Cell. Immunol. 25, 178–188 (1976).

    Article  CAS  Google Scholar 

  16. Shijirslev, S.V. and Kevorkov, N.N. Relationship between the immunomodulating effects of chorionic gonadotropin and the intense functional activity of the splenocytes mediating the adoptive immune response. Probl. Endokrinal. [Mosk] 39, 54–57 (1993).

    Google Scholar 

  17. Albini, A. et al. The beta-core fragment of human chorionic gonadotropin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 11, 713–721 (1997).

    Article  CAS  Google Scholar 

  18. Bourinbaiar, A.S. & Lee-Huang, S. Anti-HIV effect of beta subunit of human chorionic gonadotropin (βhCG) in vitro. Immunol. Lett. 44, 13–18 (1995).

    Article  CAS  Google Scholar 

  19. Swapan, D.E. et al. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice. J. Clin. Invest. 99, 1484–1491 (1997).

    Article  Google Scholar 

  20. Griffiths, S.J. Ribonuclease inhibits Kaposi's sarcoma. Nature 390, 568 (1997).

    Article  CAS  Google Scholar 

  21. Klotman, M.E. et al. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA 88, 5011–5015 (1991).

    Article  CAS  Google Scholar 

  22. Popovic, M. et al. Detection, isolation, and continuous production of cyto-pathic retroviruses (HTLV-III) form patients with AIDS and pre-AIDS. Science 224, 497–500 (1984).

    Article  CAS  Google Scholar 

  23. Gallo, R.C. et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500–503 (1984).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lunardi-Iskandar, Y., Bryant, J., Blattner, W. et al. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med 4, 428–434 (1998). https://doi.org/10.1038/nm0498-428

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0498-428

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing